1-3 of 3
John C. Markley
Close
Sort by
Journal Articles

Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo

e-blood
Il-Kang Na, John C. Markley, Jennifer J. Tsai, Nury L. Yim, Bradley J. Beattie, Alexander D. Klose, Amanda M. Holland, Arnab Ghosh, Uttam K. Rao, Matthias T. Stephan, Inna Serganova, Elmer B. Santos, Renier J. Brentjens, Ronald G. Blasberg, Michel Sadelain, Marcel R. M. van den Brink
Journal: Blood
Blood (2010) 116 (11): e18–e25.
https://doi.org/10.1182/blood-2009-12-259432
Published: 2010
Includes: Supplemental data
Journal Articles

IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell–mediated rejection of systemic lymphoma in immunodeficient mice

John C. Markley, Michel Sadelain
Journal: Blood
Blood (2010) 115 (17): 3508–3519.
https://doi.org/10.1182/blood-2009-09-241398
Published: 2010
Includes: Supplemental data
Journal Articles

Targeted ‘Off-the-Shelf’ Tumor Immunotherapy Using Allogeneic T-Cell Precursors.

Johannes L. Zakrzewski, MD, David Suh, Odette M. Smith, Christopher King, Gabrielle L. Goldberg, PhD, Robert Jenq, MD, Amanda M. Holland, Jeremy Grubin, Sydney X. Lu, Javier Cabrera-Perez, Gabrielle Rizzuto, Derek B. Sant’Angelo, PhD, Marcel R.M. van den Brink, MD, PhD, John C. Markley, Isabelle Riviere, PhD, Michel Sadelain, MD, PhD, Juan Carlos Zuniga-Pflucker, PhD
Journal: Blood
Blood (2007) 110 (11): 579.
https://doi.org/10.1182/blood.V110.11.579.579
Published: 2007